
Jessica N. Worsham
Examiner (ID: 16444, Phone: (571)270-7434 , Office: P/1615 )
| Most Active Art Unit | 1615 |
| Art Unit(s) | 1615 |
| Total Applications | 839 |
| Issued Applications | 425 |
| Pending Applications | 120 |
| Abandoned Applications | 329 |
Applications
| Application number | Title of the application | Filing Date | Status |
|---|---|---|---|
Array
(
[id] => 18550764
[patent_doc_number] => 20230248764
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2023-08-10
[patent_title] => TREATMENT OF BLEPHARITIS
[patent_app_type] => utility
[patent_app_number] => 18/135966
[patent_app_country] => US
[patent_app_date] => 2023-04-18
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 5794
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => 0
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18135966
[rel_patent_id] =>[rel_patent_doc_number] =>) 18/135966 | TREATMENT OF BLEPHARITIS | Apr 17, 2023 | Pending |
Array
(
[id] => 18550764
[patent_doc_number] => 20230248764
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2023-08-10
[patent_title] => TREATMENT OF BLEPHARITIS
[patent_app_type] => utility
[patent_app_number] => 18/135966
[patent_app_country] => US
[patent_app_date] => 2023-04-18
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 5794
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => 0
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18135966
[rel_patent_id] =>[rel_patent_doc_number] =>) 18/135966 | TREATMENT OF BLEPHARITIS | Apr 17, 2023 | Pending |
Array
(
[id] => 18690947
[patent_doc_number] => 20230321119
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2023-10-12
[patent_title] => STICK COMPOSITION CONTAINING CANNABINOIDS
[patent_app_type] => utility
[patent_app_number] => 18/297364
[patent_app_country] => US
[patent_app_date] => 2023-04-07
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 5866
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -16
[patent_words_short_claim] => 63
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18297364
[rel_patent_id] =>[rel_patent_doc_number] =>) 18/297364 | STICK COMPOSITION CONTAINING CANNABINOIDS | Apr 6, 2023 | Pending |
Array
(
[id] => 18536202
[patent_doc_number] => 20230241290
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2023-08-03
[patent_title] => MALLEABLE, CRYOPRESERVED OSTEOGENIC COMPOSITIONS WITH VIABLE CELLS
[patent_app_type] => utility
[patent_app_number] => 18/130484
[patent_app_country] => US
[patent_app_date] => 2023-04-04
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 2342
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -10
[patent_words_short_claim] => 19
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18130484
[rel_patent_id] =>[rel_patent_doc_number] =>) 18/130484 | MALLEABLE, CRYOPRESERVED OSTEOGENIC COMPOSITIONS WITH VIABLE CELLS | Apr 3, 2023 | Pending |
Array
(
[id] => 18815963
[patent_doc_number] => 20230390302
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2023-12-07
[patent_title] => PHARMACEUTICAL FORMULATION
[patent_app_type] => utility
[patent_app_number] => 18/295670
[patent_app_country] => US
[patent_app_date] => 2023-04-04
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 5986
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -5
[patent_words_short_claim] => 80
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18295670
[rel_patent_id] =>[rel_patent_doc_number] =>) 18/295670 | Pharmaceutical formulation | Apr 3, 2023 | Issued |
Array
(
[id] => 18466829
[patent_doc_number] => 20230201109
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2023-06-29
[patent_title] => BIO-INSPIRED TISSUE-ADHESIVE HYDROGEL PATCH FOR PREVENTING OR TREATING CARTILAGE OR BONE DISEASE
[patent_app_type] => utility
[patent_app_number] => 18/176890
[patent_app_country] => US
[patent_app_date] => 2023-03-01
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 10984
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -9
[patent_words_short_claim] => 39
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18176890
[rel_patent_id] =>[rel_patent_doc_number] =>) 18/176890 | BIO-INSPIRED TISSUE-ADHESIVE HYDROGEL PATCH FOR PREVENTING OR TREATING CARTILAGE OR BONE DISEASE | Feb 28, 2023 | Pending |
Array
(
[id] => 19011790
[patent_doc_number] => 11918691
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2024-03-05
[patent_title] => Local delivery of antineoplastic particles in combination with systemic delivery of immunotherapeutic agents for the treatment of cancer
[patent_app_type] => utility
[patent_app_number] => 18/154419
[patent_app_country] => US
[patent_app_date] => 2023-01-13
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 49
[patent_figures_cnt] => 64
[patent_no_of_words] => 58467
[patent_no_of_claims] => 14
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 128
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18154419
[rel_patent_id] =>[rel_patent_doc_number] =>) 18/154419 | Local delivery of antineoplastic particles in combination with systemic delivery of immunotherapeutic agents for the treatment of cancer | Jan 12, 2023 | Issued |
Array
(
[id] => 18509920
[patent_doc_number] => 20230226006
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2023-07-20
[patent_title] => Compositions for the Treatment of Dry Eye and Methods of Use Thereof
[patent_app_type] => utility
[patent_app_number] => 18/082275
[patent_app_country] => US
[patent_app_date] => 2022-12-15
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 9914
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -17
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18082275
[rel_patent_id] =>[rel_patent_doc_number] =>) 18/082275 | Compositions for the Treatment of Dry Eye and Methods of Use Thereof | Dec 14, 2022 | Abandoned |
Array
(
[id] => 18535911
[patent_doc_number] => 20230240997
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2023-08-03
[patent_title] => METHOD OF TREATING CANCER
[patent_app_type] => utility
[patent_app_number] => 18/077390
[patent_app_country] => US
[patent_app_date] => 2022-12-08
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 48573
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -21
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18077390
[rel_patent_id] =>[rel_patent_doc_number] =>) 18/077390 | METHOD OF TREATING CANCER | Dec 7, 2022 | Abandoned |
Array
(
[id] => 18739504
[patent_doc_number] => 20230348438
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2023-11-02
[patent_title] => PYRAZOLE COMPOUND AND PHARMACEUTICAL USE THEREOF
[patent_app_type] => utility
[patent_app_number] => 18/061309
[patent_app_country] => US
[patent_app_date] => 2022-12-02
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 44108
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -14
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18061309
[rel_patent_id] =>[rel_patent_doc_number] =>) 18/061309 | PYRAZOLE COMPOUND AND PHARMACEUTICAL USE THEREOF | Dec 1, 2022 | Pending |
Array
(
[id] => 18626547
[patent_doc_number] => 20230285334
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2023-09-14
[patent_title] => THERAPEUTIC COMPOUNDS, FORMULATIONS, AND USES THEREOF
[patent_app_type] => utility
[patent_app_number] => 18/059270
[patent_app_country] => US
[patent_app_date] => 2022-11-28
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 21709
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -19
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18059270
[rel_patent_id] =>[rel_patent_doc_number] =>) 18/059270 | Therapeutic compounds, formulations, and uses thereof | Nov 27, 2022 | Issued |
Array
(
[id] => 19839101
[patent_doc_number] => 12251457
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2025-03-18
[patent_title] => Self-neutralizing amino acid based cationic compositions
[patent_app_type] => utility
[patent_app_number] => 18/070021
[patent_app_country] => US
[patent_app_date] => 2022-11-28
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 4
[patent_figures_cnt] => 4
[patent_no_of_words] => 7572
[patent_no_of_claims] => 23
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 158
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18070021
[rel_patent_id] =>[rel_patent_doc_number] =>) 18/070021 | Self-neutralizing amino acid based cationic compositions | Nov 27, 2022 | Issued |
Array
(
[id] => 19241086
[patent_doc_number] => 12011502
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2024-06-18
[patent_title] => Compositions and methods of administering baclofen
[patent_app_type] => utility
[patent_app_number] => 17/984001
[patent_app_country] => US
[patent_app_date] => 2022-11-09
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 9717
[patent_no_of_claims] => 12
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 107
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17984001
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/984001 | Compositions and methods of administering baclofen | Nov 8, 2022 | Issued |
Array
(
[id] => 18339119
[patent_doc_number] => 20230131068
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2023-04-27
[patent_title] => METHODS OF TREATING ENDOMETRIAL CANCER USING HEMP EXTRACT
[patent_app_type] => utility
[patent_app_number] => 18/050021
[patent_app_country] => US
[patent_app_date] => 2022-10-26
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 24623
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -17
[patent_words_short_claim] => 33
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18050021
[rel_patent_id] =>[rel_patent_doc_number] =>) 18/050021 | Methods of treating endometrial cancer using hemp extract | Oct 25, 2022 | Issued |
Array
(
[id] => 18383367
[patent_doc_number] => 11654131
[patent_country] => US
[patent_kind] => B1
[patent_issue_date] => 2023-05-23
[patent_title] => Composition and method of treatment of health issues related to estrogen metabolism with elevated risk factors in females
[patent_app_type] => utility
[patent_app_number] => 17/966901
[patent_app_country] => US
[patent_app_date] => 2022-10-17
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 17
[patent_figures_cnt] => 17
[patent_no_of_words] => 10640
[patent_no_of_claims] => 12
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 85
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17966901
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/966901 | Composition and method of treatment of health issues related to estrogen metabolism with elevated risk factors in females | Oct 16, 2022 | Issued |
Array
(
[id] => 18443545
[patent_doc_number] => 11679096
[patent_country] => US
[patent_kind] => B1
[patent_issue_date] => 2023-06-20
[patent_title] => Composition and method of treatment of elevated ApoE gene expression related health issues
[patent_app_type] => utility
[patent_app_number] => 17/966916
[patent_app_country] => US
[patent_app_date] => 2022-10-17
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 17
[patent_figures_cnt] => 17
[patent_no_of_words] => 10810
[patent_no_of_claims] => 12
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 120
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17966916
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/966916 | Composition and method of treatment of elevated ApoE gene expression related health issues | Oct 16, 2022 | Issued |
Array
(
[id] => 18307388
[patent_doc_number] => 20230111288
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2023-04-13
[patent_title] => Treatment of Epithelial Cysts by Intracystic Injection of Antineoplastic Particles
[patent_app_type] => utility
[patent_app_number] => 18/046002
[patent_app_country] => US
[patent_app_date] => 2022-10-12
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 19182
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -18
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18046002
[rel_patent_id] =>[rel_patent_doc_number] =>) 18/046002 | Treatment of epithelial cysts by intracystic injection of antineoplastic particles | Oct 11, 2022 | Issued |
Array
(
[id] => 18194839
[patent_doc_number] => 20230048358
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2023-02-16
[patent_title] => EDIBLE COMPOSITION FOR ALLEVIATING VISUAL FATIGUE
[patent_app_type] => utility
[patent_app_number] => 17/962753
[patent_app_country] => US
[patent_app_date] => 2022-10-10
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 4932
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -10
[patent_words_short_claim] => 45
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17962753
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/962753 | Edible composition for alleviating visual fatigue | Oct 9, 2022 | Issued |
Array
(
[id] => 19081878
[patent_doc_number] => 20240108679
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2024-04-04
[patent_title] => Composition and manufacturing processes of a toxicity free botanical drug for relief from breathing difficulties
[patent_app_type] => utility
[patent_app_number] => 17/958322
[patent_app_country] => US
[patent_app_date] => 2022-10-01
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 2156
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -2
[patent_words_short_claim] => 42
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17958322
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/958322 | Composition and manufacturing processes of a toxicity free botanical drug for relief from breathing difficulties | Sep 30, 2022 | Pending |
Array
(
[id] => 19081878
[patent_doc_number] => 20240108679
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2024-04-04
[patent_title] => Composition and manufacturing processes of a toxicity free botanical drug for relief from breathing difficulties
[patent_app_type] => utility
[patent_app_number] => 17/958322
[patent_app_country] => US
[patent_app_date] => 2022-10-01
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 2156
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -2
[patent_words_short_claim] => 42
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17958322
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/958322 | Composition and manufacturing processes of a toxicity free botanical drug for relief from breathing difficulties | Sep 30, 2022 | Pending |